Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/15/2012 | US20120064541 N-glycan core beta-galactosyltransferase and uses thereof |
03/15/2012 | US20120064524 Tumor suppressor gene, p47ing3 |
03/15/2012 | US20120064514 Hiv-1-c resistance monitoring |
03/15/2012 | US20120064194 Enzymes |
03/15/2012 | US20120064117 Tetravalent influenza vaccine and use thereof |
03/15/2012 | US20120064116 Influenza nucleic acid molecules and vaccines made therefrom |
03/15/2012 | US20120064115 Recombinant virus-like particles encoded by multi-gene vector |
03/15/2012 | US20120064114 Use of e. coli surface antigen 3 sequences for the export of heterologous antigens |
03/15/2012 | US20120064112 Recombinant newcastle disease viruses useful as vaccines or vaccine vectors |
03/15/2012 | US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa |
03/15/2012 | US20120064093 Antibody |
03/15/2012 | US20120064084 Signal transduction protein tab2 |
03/15/2012 | US20120064077 Stable and soluble antibodies inhibiting tnf alpha |
03/15/2012 | US20120064074 Antigen binding domains |
03/15/2012 | US20120064059 Fusion proteins |
03/15/2012 | US20120064038 Epidermal growth factor receptor (egfr) and methods of use in adenoviral-associated virus type 6 (aav6) transduction |
03/15/2012 | US20120064031 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases |
03/15/2012 | US20120064001 Anti-VEGF Antibody Compositions and Methods |
03/15/2012 | US20120064000 Human Monoclonal Antibodies Against Hendra And Nipah Viruses |
03/15/2012 | US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody |
03/15/2012 | US20120063995 Non-ad5 adenoviral vectors and methods and uses related thereto |
03/15/2012 | US20120063994 Rtef-1 variants and uses thereof |
03/15/2012 | US20120060413 Increasing carbon flow for polyhydroxybutyrate production in biomass crops |
03/15/2012 | CA2810950A1 Sdf-1 binding nucleic acids and the use thereof in cancer treatment |
03/15/2012 | CA2810698A1 Composition for preventing inflammations |
03/15/2012 | CA2810636A1 Ttll4 peptides and vaccines containing the same |
03/15/2012 | CA2810527A1 Detection of chromatin structure |
03/15/2012 | CA2810520A1 Size selection of dna for chromatin analysis |
03/15/2012 | CA2810244A1 Integration of a polynucleotide encoding a polypeptide that catalyzes pyruvate to acetolactate conversion |
03/15/2012 | CA2809457A1 Modifications for antisense compounds |
03/14/2012 | EP2428798A1 Fusion analyte cytometric bead assay, and systems and kits for performing the same |
03/14/2012 | EP2428588A2 Recombinase Polymerase Amplification |
03/14/2012 | EP2428578A1 Glucuronic acid-containing glucan, process for production of same, and use of same |
03/14/2012 | EP2428573A2 Improved production of bacterial strains cross reference to related applications |
03/14/2012 | EP2428572A2 Alkaliphilic Bacillus species alpha-amylase variants, compositions comprising alpha-amylase variants, and methods of use |
03/14/2012 | EP2428571A1 MicroRNA molecules |
03/14/2012 | EP2428570A1 MicroRNA molecules |
03/14/2012 | EP2428569A1 MicroRNA molecules |
03/14/2012 | EP2428568A1 MicroRNA molecules |
03/14/2012 | EP2428567A1 MicroRNA molecules |
03/14/2012 | EP2428566A1 Gene transfer agent composition containing polyamidoamine dendron |
03/14/2012 | EP2428564A1 A hepatitis b virus mutation strain with resistance to adefovir dipivoxil and the uses thereof |
03/14/2012 | EP2428522A1 Antibodies that bind to PSCA proteins for diagnosis of cancer |
03/14/2012 | EP2428229A1 Oncolytic adenoviruses for treating cancer |
03/14/2012 | EP2428227A1 Compositions and their uses directed to Huntingtin |
03/14/2012 | EP2428226A1 Antibody targeting compounds |
03/14/2012 | EP2428115A1 Genetically modified silkworm for producing recombinant spider dragline protein |
03/14/2012 | EP2427776A1 Method for the determination of p blood groups |
03/14/2012 | EP2427577A2 Cocal vesiculovirus envelope pseudotyped retroviral vectors |
03/14/2012 | EP2427575A2 Methods and compositions for diagnosis of thyroid conditions |
03/14/2012 | EP2427572A2 Sequencing methods |
03/14/2012 | EP2427569A1 The use of class iib restriction endonucleases in 2nd generation sequencing applications |
03/14/2012 | EP2427558A1 Dhx36 / rhau knockout mice as experimental models of muscular dystrophy |
03/14/2012 | EP2427557A1 Cho / cert cell lines |
03/14/2012 | EP2427556A1 Increasing protein production b\ increasing abc50 expression or activity |
03/14/2012 | EP2427555A1 Dfpase enzymes from aplysia californica |
03/14/2012 | EP2427554A2 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
03/14/2012 | EP2427553A2 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
03/14/2012 | EP2427552A2 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp |
03/14/2012 | EP2427551A1 Efficient light harvesting |
03/14/2012 | EP2427544A1 Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid |
03/14/2012 | EP2427489A1 Method of controlling o-linked glycosylation of antibodies |
03/14/2012 | EP2427481A1 Yield enhancement in plants by modulation of ap2 transcription factor |
03/14/2012 | EP2427480A1 Plants having enhanced yield-related traits and/or enhanced abiotic stress tolerance and a method for making the same |
03/14/2012 | EP2427471A2 Novel sugar transporters |
03/14/2012 | EP2427180A1 Prevention and treatment of nosema disease in bees |
03/14/2012 | EP2427047A2 Materials and methods for regeneration and transformation of trees |
03/14/2012 | EP2405018A9 Method for determining fatty acid synthesis pathway of microorganism, and pcr primer set for use in the method |
03/14/2012 | EP2205750B1 Controlled activation of non-ltr retrotransposons in mammals |
03/14/2012 | EP2195452B1 Methods and compositions for universal size-specific polymerase chain reaction |
03/14/2012 | EP2089546B1 Methods of diagnosing osteoarthritis |
03/14/2012 | EP1974037B1 Linear vectors, host cells and cloning methods |
03/14/2012 | EP1971688B1 Dsrna as insect control agent |
03/14/2012 | EP1966373B1 Polypeptide having esterase activity and recombinant esterase and use thereof |
03/14/2012 | EP1944365B1 Novel bacillus subtilis mutant strain |
03/14/2012 | EP1911843B1 Genetically modified microorganism and process for production of macrolide compound using the microorganism |
03/14/2012 | EP1869085B1 Novel anti-plgf antibody |
03/14/2012 | EP1852442B1 Antibody for assay of adamts13 activity and method of activity assay |
03/14/2012 | EP1804839B1 Improved expression of factor ix in gene therapy vectors |
03/14/2012 | EP1648996B1 Enzymes for starch processing |
03/14/2012 | EP1613658B1 Antibodies against insulin-like growth factor i receptor and uses thereof |
03/14/2012 | EP1599586B9 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
03/14/2012 | EP1590447B1 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
03/14/2012 | EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
03/14/2012 | EP1448984B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
03/14/2012 | EP1436003B3 Taci-immunoglobulin fusion proteins |
03/14/2012 | EP1332218B1 Differentiation-inducing substances |
03/14/2012 | EP1198564B1 Mutant bacterial strains for l-lysine production |
03/14/2012 | CN1950509B High lysine maize compositions and methods for detection thereof |
03/14/2012 | CN1922311B Desaturase enzymes |
03/14/2012 | CN1558774B Angiotensin peptide-carrier conjugates and uses thereof |
03/14/2012 | CN102378814A Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
03/14/2012 | CN102378765A Glycosaminoglycan-antagonising mcp-i mutants and methods of using same |
03/14/2012 | CN102378633A Immunologic adjuvant composition and use thereof |
03/14/2012 | CN102375062A Detection method of lactobacillus micro integral membrane protein active fragments |
03/14/2012 | CN102373511A Method for fast, simple and convenient construction of next-generation high-throughput sequencing library |
03/14/2012 | CN102373299A PCV2 (Porcine Circovirus 2), PRV (Pseudorabies Virus) and SIV (Swine Influenza Virus) H9 subtype multiplex SYBR Green I real-time fluorescence PCR (Polymerase Chain Reaction) primer and detection method thereof |
03/14/2012 | CN102373298A CSFV (Classical Swine Fever Virus), PRRSV (Porcine Reproductive and Respiratory Syndrome Virus), PCV2 (Porcine Circovirus 2) and SIV (Swine Influenza Virus) H9 subtype multiplex SYBR Green I real-time fluorescence PCR (Polymerase Chain Reaction) primer and detection method thereof |
03/14/2012 | CN102373297A CSFV (Classical Swine Fever Virus), PRRSV (Porcine Reproductive and PCV2 (Porcine Circovirus 2) multiplex SYBR Green I real-time fluorescence PCR (Polymerase Chain Reaction) primer and detection method thereof |
03/14/2012 | CN102373296A PRRSV (Porcine Reproductive and Respiratory Syndrome Virus), SIV (Swine Influenza Virus) H9 subtype and PCV2 (Porcine Circovirus 2) multiplex SYBR Green I real-time fluorescence PCR (Polymerase Chain Reaction) primer and detection method thereof |